Market Place
Sourcing Support
All News #Library
Others
Be Biopharma Publishes In Vivo Plasma Cell Engraftment Data
06 Feb 2025 //
BUSINESSWIRE
Be Biopharma to Present at the 43rd Annual J.P. Morgan Conference
07 Jan 2025 //
BUSINESSWIRE
Be Biopharma Unveils BeCoMe-9 Trial, Presents B Cell Platform
08 Dec 2024 //
BUSINESSWIRE
Be Bio Announces $82M Financing And Clinical Stage Transition
22 Oct 2024 //
BUSINESSWIRE
Be Bio Novel B Cell Hypophosphatasia Data
10 May 2024 //
BUSINESSWIRE
Be Biopharma to Present at ASGCT Annual Meeting
23 Apr 2024 //
BUSINESSWIRE
MaxCyte Signs Strategic Platform License with Be Biopharma
02 Apr 2024 //
GLOBENEWSWIRE
Be Biopharma to Present at the 20th Annual WORLDSymposium™ 2024
01 Feb 2024 //
BUSINESSWIRE
Be Biopharma to Present at Keystone Symposia on Emerging Cellular Therapies
25 Jan 2024 //
BUSINESSWIRE
Be Biopharma Expands Leadership Team
04 Jan 2024 //
BUSINESSWIRE
Be Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
28 Dec 2023 //
BUSINESSWIRE
Be Biopharma to Present at 2023 Cell & Gene Meeting on the Mesa
11 Oct 2023 //
BUSINESSWIRE
Be Biopharma to Present at the Jefferies Healthcare Conference
25 May 2023 //
BUSINESSWIRE
Be Biopharma Appoints John Mayfield, Ph.D., as Chief Business Officer
08 Dec 2022 //
BUSINESSWIRE
Resilience inks manufacturing pact with ARCH-backed cell therapy startup
19 May 2022 //
ENDPTS
Be Bio raises $130m to develop engineered B cell medicines
15 Apr 2022 //
PHARMACEUTICAL-TECHNOLOGY
Be Bio Closes $130M Financing to Pioneer Engineered B Cells
14 Apr 2022 //
BUSINESSWIRE
Be Bio Appoints Mitchell Chan as CFO & Head of Corporate Strategy
21 Sep 2021 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.